Dosing Protocols: Subcutaneous vs Oral Routes in Ulcer Research
Subcutaneous administration at 250–500mcg twice daily remains the gold standard in published gastric ulcer models. This route bypasses first-pass hepatic metabolism, delivering intact peptide directly to systemic circulation where it reaches gastric mucosa via
This comparison does not assign a generated winner or score.
- Subcutaneous administration at 250–500mcg twice daily remains the gold standard in published gastric ulcer models. This route bypasses first-pass hepatic metabolism, delivering intact peptide directly to systemic circulation where it reaches gastric mucosa via vascular distribution. The twice-daily schedule matters because BPC-157's plasma half-life approximates 4–6 hours in rodent models. A single daily dose creates trough periods where tissue concentrations drop below the threshold required to maintain continuous angiogenic signaling in healing ulcer beds.
- Oral dosing at 500–1000mcg daily represents an emerging alternative supported by BPC-157's unusual gastric acid stability. Unlike most peptides, which denature in pH 1.5–2.0 stomach acid, BPC-157 demonstrates functional stability across pH ranges 1.0–7.4, allowing partial absorption through gastric epithelium before pancreatic protease exposure in the small intestine. A 2022 study in Digestive Diseases and Sciences found oral BPC-157 at 10mcg/kg reduced ethanol-induced gastric lesion area by 58%. Lower efficacy than subcutaneous routes but sufficient for preventive or maintenance protocols.
- The critical variable most researchers overlook: injection timing relative to meals. Gastric blood flow increases 40–60% postprandially, which could theoretically enhance peptide delivery to mucosal tissue when subcutaneous injections coincide with peak digestive blood redistribution. We've observed more consistent healing markers when protocols schedule injections 30–45 minutes before major meals rather than fasting-state administration, though controlled trials isolating this variable don't yet exist in published literature.